Cardiologia
Uso de drogas por doadores não está associado com piora na sobrevida do receptor de transplante cardíaco – “Aumento do uso de tais doadores pode ajudar a aliviar a escassez crônica de doadores.”
2 Ago, 2021 | 17:58hIntoxicated Donors and Heart Transplant Outcomes: Long-Term Safety – Circulation: Heart Failure
Comentário: Donor Drug Use Not Tied to Survival for Heart Transplant Recipients – HealthDay
Estudo relacionado: National Trends in Heart Donor Usage Rates: Are We Efficiently Transplanting More Hearts? – Circulation: Heart Failure
Posicionamento Científico ESC | Efeitos metabólicos, cardíacos e renais dos inibidores de SGLT2.
2 Ago, 2021 | 17:29hRevisão | Lipoproteína(a) e doenças cardiovasculares.
2 Ago, 2021 | 17:12hLipoprotein(a) and Cardiovascular Diseases – JAMA (gratuito por tempo limitado)
Consenso ESC | Terapias antitrombóticas nas doenças arteriais aórticas e periféricas em 2021.
2 Ago, 2021 | 16:44hPontos principais a lembrar: ESC Consensus on Antithrombotic Therapies in Aortic and Peripheral Artery Diseases – American College of Cardiology
Comentário no Twitter
The new consensus document from the ESC working group on aorta and peripheral vascular diseases on best antithrombotic strategies!#aorta #antithrombotic #therapy #EHJ #cardiotwitter@escardio @ESC_Journals https://t.co/ga17wxKDGi pic.twitter.com/CSSgE5TFdX
— EHJ Editor-in-Chief (@ehj_ed) July 23, 2021
Consenso de especialistas | Exames de imagem na análise da viabilidade miocárdica.
2 Ago, 2021 | 16:36hConteúdo relacionado: Review | Myocardial perfusion and viability imaging in coronary artery disease: clinical value in diagnosis, prognosis and therapeutic guidance.
Comentário no Twitter
Proud to be actor of the EACVI expert consensus document about MMI of myocardial viability.
Congratulations to @bernhard_gerber for the magnificent job as work leader!https://t.co/wewpY5BVGQ@carpenter_jp @DonalErwan @sven_plein @denisamuraru @maceiraCMR @MarcDweck @unisiena pic.twitter.com/kdxZL3wQxW— Matteo Cameli, MD, PhD (@Matte_Cameli) June 8, 2021
Revisão | Uma abordagem fisiopatológica para personalizar o tratamento medicamentoso da angina.
27 Jul, 2021 | 10:16hA pathophysiological compass to personalize antianginal drug treatment – Nature Reviews Cardiology (gratuito por tempo limitado)
Comentário no Twitter
A Review in @NatRevCardiol discusses the pathophysiology of angina in the context of the underlying cardiovascular condition and the modes of action of antianginal drugs to provide the clinician with a rationale and compass of when to use them. https://t.co/iS0sJsvOJu pic.twitter.com/jVmZo8iHY7
— Nature Portfolio (@NaturePortfolio) July 26, 2021
Relatório AHA | Recomendações para a divulgação de dados estatísticos na medicina cardiovascular.
27 Jul, 2021 | 10:11h
Comentário no Twitter (fio – clique para saber mais)
It's great to see @AHA_Research & @ADAlthousePhD recommend more transparent data visualization & clearer statistical reporting, and advocate for pre-registration, open data & open code in their new guidelines. I look forward to seeing this implemented.https://t.co/Wm2pmSmCbe pic.twitter.com/k0zvwYtKps
— Tracey Weissgerber (@T_Weissgerber) June 14, 2021
Estudo de coorte mostrou que 1 em cada 2 pacientes hospitalizados com COVID-19 desenvolve complicação.
26 Jul, 2021 | 10:23hComentários:
In-hospital complications associated with COVID-19 – The Lancet
CV Complications Common in Hospitalized COVID-19 Patients – TCTMD
Almost Half of Patients Admitted With COVID-19 Have Complications – HealthDay
Comentário no Twitter (fio – clique para saber mais)
NEW—An observational study of >70,000 people in the UK hospitalised with severe #COVID19 finds 1 in 2 developed at least one health complication. Authors warn of significant challenges for individuals and health & social care in the coming years.
🔗 https://t.co/CTLsPJcGZ7 pic.twitter.com/voMEDVXO9U
— The Lancet (@TheLancet) July 15, 2021
Diretriz de consenso internacional sobre a nomenclatura e a classificação da válvula aórtica bicúspide congênita e sua aortopatia para fins clínicos, cirúrgicos, intervencionistas e de pesquisa.
26 Jul, 2021 | 10:08h
Comentário no Twitter
Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve https://t.co/Uux9d40kkj pic.twitter.com/LA8dfuWv90
— CM Otto (@ottoecho) July 22, 2021
Revisão | Momento e conclusão da revascularização em síndromes coronárias agudas.
26 Jul, 2021 | 10:02hTiming and completeness of revascularisation in acute coronary syndromes – Heart
Comentário no Twitter
Education: Timing and completeness of revascularisation in acute coronary syndromes https://t.co/VBQ76c3545 pic.twitter.com/tpNaZfhrxI
— Heart_BMJ (@Heart_BMJ) July 22, 2021